ECS FY26 Results

• Revenue increased 10% to $21.4 million in FY26
• Branded B2C revenue grew 101% to $13.7 million
• EBITDA improved by $5.8 million to $0.6 million
• Net operating cash flow turned positive to $0.5 million
• International expansion advanced with new markets in Germany and Poland

ECS Botanics Holdings Ltd (ASX:ECS) reported a significant improvement in its financial performance for the year ended 30 June 2026. The company delivered positive EBITDA and operating cash flow, marking a material transition in its financial and operating profile. Revenue increased by 10% to $21.4 million, while EBITDA improved by $5.8 million to $0.6 million, turning from a $5.2 million loss in the previous year. Net operating cash flow also improved, with an inflow of $0.5 million compared to an outflow of $5.1 million in FY25. The company's branded B2C revenue grew by 101% to $13.7 million, representing approximately 65% of annual revenue. ECS also achieved significant production cost reductions, with a 33% decrease in average production cost per gram across the Protective Cropping Enclosure (PCE) network and a 44% reduction for outdoor cultivation. International expansion was a key highlight, with the commercial launch of OzSun in Germany, a repeat order from New Zealand, and regulatory approval of the company's first product in Poland.

Revenue increased 10% to $21.4 million, EBITDA improved to $0.6 million, and net operating cash flow turned positive to $0.5 million.

ECS Botanics plans to focus on growing branded sales, scaling international opportunities, increasing export revenue, and maintaining disciplined cost management in FY27.